CST7 and hepatocellular carcinoma: Moreover, it was disclosed that CST7 exhibited significant enrichment in cancer progenitors, liver cancer advancement, tumor evasion and tolerogenicity, late recurrence of liver cancer, and various subclasses of hepatocellular carcinoma [24].